President Trump has offered sketchy and sometimes contradictory details in his recent trade frameworks. Yet markets don't ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...

Spain's black olive exporters, who adapted to survive harsh tariffs from U.S. President Donald Trump's first term, are ...

James Knightley, ING’s chief international economist, said the deal with the European Union is important. But he said there ...

Euro falls against dollar, with Trump's tariffs seen as slowing European growth ...

The IMF on Tuesday raised its global growth forecasts for 2025 and 2026 slightly, citing stronger-than-expected purchases ...

Retailers rushing to stock up before expected tariffs have boosted the Port of Savannah to its second-busiest year.

The United States has struck deals over tariffs with some of its key trading partners — including Britain, Japan and the ...

Investor confidence has been lost after numerous execution failures. Given strategic uncertainty, risks remain. However, there is also significant room for improvement off a severely depressed base.

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal ...

The U.S. stock market has shown relief the tariff rates aren’t as high as Trump initially threatened in April and hope for a sense of stability going forward. Trump maintains the tariff revenues will ...

Republicans are divided on the value of Ghislaine Maxwell as she takes center stage in the Jeffrey Epstein files saga. Some view the convicted sex trafficker as the key to unlocking additional ...